Emerging principles for the therapeutic exploitation of glycosylation.
about
Glycan and lectin biosensorsAdvances in Fmoc solid-phase peptide synthesisThe HIV glycan shield as a target for broadly neutralizing antibodiesElectrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsCrossroads between Bacterial and Mammalian GlycosyltransferasesN-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytesCanonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesTotal synthesis of glycosylated proteinsN-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding CycleProperties of protein drug target classesOptimal Synthetic Glycosylation of a Therapeutic AntibodyOptimal Synthetic Glycosylation of a Therapeutic AntibodyConsistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab).Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Ultrasensitive detection of influenza viruses with a glycan-based impedimetric biosensor.Integration of systems glycobiology with bioinformatics toolboxes, glycoinformatics resources, and glycoproteomics data.Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders.N-glycosylation is required for matriptase-2 autoactivation and ectodomain sheddingBiological significance of complex N-glycans in plants and their impact on plant physiologyGlycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses.Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding.The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis.Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation.Recent advances in employing molecular modelling to determine the specificity of glycan-binding proteins.Role of siglecs and related glycan-binding proteins in immune responses and immunoregulationIn vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4.Carboxybetaine Modified Interface for Electrochemical Glycoprofiling of Antibodies Isolated from Human Serum.A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to MalignancyEndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycansmiRNA proxy approach reveals hidden functions of glycosylationMUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.Rapid and sensitive MALDI MS analysis of oligosaccharides by using 2-hydrazinopyrimidine as a derivative reagent and co-matrix.CP40 from Corynebacterium pseudotuberculosis is an endo-β-N-acetylglucosaminidase.Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected PeptidesSialylation of IgG Fc domain impairs complement-dependent cytotoxicity.Mass spectrometry-based analyses showing the effects of secretor and blood group status on salivary N-glycosylation.On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry.The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice.
P2860
Q26745873-7B91007E-5C8E-432E-9F7A-7C120EC254F1Q26770921-923BA0D6-D8E1-499D-9DC7-13132CD96809Q26786540-5A49325C-72C7-4C72-8BDE-A8C1485F6957Q26822552-AD699C78-3246-4594-8C08-3ABADAD58392Q26866347-758A11A3-47D3-43D4-A43F-4F62DD3E4206Q27334228-65EE2969-5BDE-453B-9AE2-930516842994Q27342723-15C47203-71EF-4E12-886A-B027CF4580EBQ28069362-A18D22B5-3EA5-4460-A2BA-3490ABDD72FEQ28083496-A0288656-6B6D-4677-B4F2-61081DB41253Q28085581-D7321554-A4AC-4DCA-A7B5-AC1F7701E669Q28545197-C533811A-9AE1-49E2-92BD-DB3D0DBD936BQ28831266-0555FF70-2846-496D-8EDF-7F5D86540186Q28831364-6EFD4189-6874-4C87-B995-CEB1FFEC0CC9Q30377369-373DCBF3-08BC-4BDF-B79D-2FC4494F7D99Q30382105-B8B5B9E5-92B7-45AC-88FA-A9566C21C350Q30382860-500B7C7A-E314-4B69-BC31-3A8BBD0294F8Q30931283-D623592D-BEF6-41B3-8EA4-DFBDDC519BCEQ33633451-B8BBFD0F-D962-4BFB-A8BF-AB4D22CC0F05Q33888539-FF465A01-1BCF-4371-A1CE-862D2C30CDF0Q33928774-46A95896-1370-4C22-A3E9-89114141E9ADQ34066431-5AA70EDB-FAD1-4D30-A630-1E17C2ED058BQ34450973-C7637102-E374-464A-8B43-28533CAB25CCQ34512555-64053E68-1C7D-4F0B-BB14-BBEB5347672AQ34589283-A4A83062-B209-47F7-994C-86DE5F41DE4FQ34615790-EF833AC1-C0E1-47B9-B112-5788079EA726Q35164415-E2E7EFBA-2F0D-46CF-8EE6-9D3CB1FBAF17Q35191986-E5E3229F-E1EA-4658-B11B-976C60BB9553Q35654967-323325DC-2E2F-4F36-8BA2-3E423408438BQ35676012-9F208BFE-E060-4920-BBE7-3DC1BBA52475Q35679876-D46D116B-8EA4-4F07-B40B-E3BFBBDF39F6Q35686671-98CD8D62-22BE-4F75-9058-BD7D513FF306Q35740441-8BB62786-C5C5-4152-9D77-93698F59EB5CQ35898801-4E59A06B-B6ED-465F-AF14-32EDF9CE253FQ36055373-ECEBD555-FA12-409A-9062-386B7117E136Q36184582-31F2D9F2-72D5-4C2B-B26A-96C3137B53F9Q36198586-41A8E501-B40E-4503-9806-F6654534FAEFQ36266469-82EC26DD-967E-4B1B-8E16-B76722F0AA29Q36417069-622629A6-FC20-435B-9CBC-2CE4FE5AA23FQ36723089-5D8D1B8B-11CF-4FCA-8FF3-74E0168AEF3EQ36735655-C7F9B68A-41C3-49F9-B854-AA423874C9B0
P2860
Emerging principles for the therapeutic exploitation of glycosylation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Emerging principles for the therapeutic exploitation of glycosylation.
@ast
Emerging principles for the therapeutic exploitation of glycosylation.
@en
Emerging principles for the therapeutic exploitation of glycosylation.
@nl
type
label
Emerging principles for the therapeutic exploitation of glycosylation.
@ast
Emerging principles for the therapeutic exploitation of glycosylation.
@en
Emerging principles for the therapeutic exploitation of glycosylation.
@nl
prefLabel
Emerging principles for the therapeutic exploitation of glycosylation.
@ast
Emerging principles for the therapeutic exploitation of glycosylation.
@en
Emerging principles for the therapeutic exploitation of glycosylation.
@nl
P2093
P356
P1433
P1476
Emerging principles for the therapeutic exploitation of glycosylation
@en
P2093
Christopher N Scanlan
Nicole Zitzmann
Raymond A Dwek
P304
P356
10.1126/SCIENCE.1235681
P407
P577
2014-01-01T00:00:00Z